Raymed Trading Group Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 12 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.00 M
as on 24-10-2024
- Revenue 37.92%
(FY 2023)
- Profit 224.25%
(FY 2023)
- Ebitda 40.86%
(FY 2023)
- Net Worth 136.10%
(FY 2023)
- Total Assets 19.54%
(FY 2023)
About Raymed Trading Group
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹8.00 M.
Kumar Chandra, Meena Roy, and Amita Sharma serve as directors at the Company.
- CIN/LLPIN
U33112DL2012PTC232504
- Company No.
232504
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Mar 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Raymed Trading Group Private Limited offer?
Raymed Trading Group Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Corona Test Kit.
Who are the key members and board of directors at Raymed Trading Group?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kumar Chandra  | Director | 06-Mar-2012 | Current |
| Meena Roy | Director | 05-Mar-2015 | Current |
| Amita Sharma | Additional Director | 31-May-2019 | Current |
Financial Performance of Raymed Trading Group.
Raymed Trading Group Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 37.92% increase. The company also saw a substantial improvement in profitability, with a 224.25% increase in profit. The company's net worth Soared by an impressive increase of 136.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Raymed Trading Group?
In 2023, Raymed Trading Group had a promoter holding of 98.99% and a public holding of 1.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Rusbharat Affordable Education Private LimitedActive 3 years 7 months
Kumar Chandra and Amita Sharma are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 07 Mar 2024 | ₹8.00 M | Open |
How Many Employees Work at Raymed Trading Group?
Raymed Trading Group has a workforce of 4 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Raymed Trading Group, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raymed Trading Group's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
